Dual-task assessment in natalizumab-treated multiple sclerosis patients

European Neurology

Volumn 71, Issue 5-6, 2014, Pages 247-251

  Allali, Gilles ^a   Laidet, Magali ^a   Assal, Frédéric ^a   Chofflon, Michel ^a   Armand, Stéphane ^a   Lalive, Patrice H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Dual tasking; Gait disorders; Multiple sclerosis; Natalizumab; Neuropsychology

Indexed keywords

NATALIZUMAB; CORTICOSTEROID; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; DUAL-TASK PERFORMANCE (TEST); EXECUTIVE FUNCTION; FEMALE; GAIT; HUMAN; MALE; MULTIPLE SCLEROSIS; MUSCULOSKELETAL SYSTEM PARAMETERS; NEUROPSYCHOLOGICAL TEST; PHONEME; PHONEMIC FLUENCY; PRIORITY JOURNAL; SEMANTIC FLUENCY; SEMANTICS; SINGLE WALKING TASK; STRIDE LENGTH; STRIDE TIME; TASK PERFORMANCE; TREATMENT OUTCOME; WALKING SPEED; ATTENTION; COGNITION ASSESSMENT; CONTROLLED STUDY; PSYCHOLOGIC TEST; QUANTITATIVE ANALYSIS; RESPONSE TIME; STROOP TEST; TEST OF ATTENTION PERFORMANCE; WALKING; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY; BIOMECHANICS; DRUG EFFECTS; FOLLOW UP; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOMECHANICAL PHENOMENA; COGNITION; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; GAIT; HUMANS; IMMUNOLOGIC FACTORS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME; WALKING;

EID: 84901677090     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000357217     Document Type: Article

References (26)

1. Beauchet O, Allali G, Berrut G, Hommet C, Dubost V, Assal F: Gait analysis in demented subjects: Interests and perspectives. Neuropsychiatr Dis Treat 2008; 4: 155-160. (Pubitemid 351460986
2. Scheinberg L, Holland N, Larocca N, Laitin P, Bennett A, Hall H: Multiple sclerosis; earning a living. NY State J Med 1980; 80: 1395-1400
3. Amato MP, Zipoli V, Portaccio E: Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245: 41-46. (Pubitemid 43775956
4. Chiaravalloti ND, DeLuca J: Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151
5. Hamilton F, Rochester L, Paul L, Rafferty D, O'Leary CP, Evans JJ: Walking and talking: An investigation of cognitive-motor dual tasking in multiple sclerosis. Mult Scler 2009; 15: 1215-1227
6. Kalron A, Dvir Z, Achiron A: Walking while talking-difficulties incurred during the initial stages of multiple sclerosis disease process. Gait Posture 2010; 32: 332-335
7. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302
8. Van der Linden M, Adam S (eds): L'évaluation des troubles de la mémoire: Présentation des quatre tests de mémoire épisodique (avec leur étalonnage). Marseille, Solal, 2004
9. Cardebat D, Doyon D, Puel M, Goulet P, Joanette Y: Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 1990; 90: 207-217
10. Strauss E, Sherman E, Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, ed 3. New York, Oxford University Press, 2006, p 8
11. Tombaugh TN: Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol 2004; 19: 203-214
12. Zimmermann P, Fimm B: Test for attentional performance (TAP). Herzogenrath: PsyTest, 1995
13. Godefroy O; GREFEX: Fonctions exécutives et pathologies neurologiques et psychatriques. Marseille, Solal, 2008
14. Wechsler D: Wechsler Adult Intelligence Scale, ed 3 (WAIS-3 ®) . San Antonio, Harcourt Assessment, 1997
15. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983; 67: 361-370. (Pubitemid 13098606
16. Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C: Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 2005; 34: 614-619. (Pubitemid 41700006
17. Mattioli F, Stampatori C, Capra R: The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: Preliminary results of a 1-year followup study. Neurol Sci 2011; 32: 83-88
18. Mattioli F, Stampatori C, Bellomi F, Capra R: Natalizumab efficacy on cognitive impairment in MS. Neurol Sci 2011; 31(suppl 3):321-323
19. Belachew S, Phan-Ba R, Bartholome E, Delvaux V, Hansen I, Calay P, et al: Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis. Eur J Neurol 2010; 18: 240-245
20. Sheridan PL, Solomont J, Kowall N, Hausdorff JM: Influence of executive function on locomotor function: Divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc 2003; 51: 1633-1637. (Pubitemid 37409600
21. Allali G, Dubois B, Assal F, Lallart E, de Souza LC, Bertoux M, et al: Frontotemporal dementia: Pathology of gait?. Mov Disord 2010; 25: 731-737
22. Pashler H: Dual-Task interference in simple tasks: Data and theory. Psychol Bull 1994; 116: 220-244
23. Allali G, Kressig RW, Assal F, Herrmann FR, Dubost V, Beauchet O: Changes in gait while backward counting in demented older adults with frontal lobe dysfunction. Gait Posture 2007; 26: 572-576. (Pubitemid 47422404
24. Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O: Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 946-947. (Pubitemid 351652394
25. Armand S, Allet L, Landis T, Beauchet O, Assal F, Allali G: Interest of dual-Task-related gait changes in idiopathic normal pressure hydrocephalus. Eur J Neurol 2011; 18: 1081-1084
26. Duncan RP, Earhart GM: Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil Neural Repair 2012; 26: 132-143